Kelyniam Global, Inc. 是一家醫療器材製造公司,專注於運用電腦輔助設計與電腦輔助製造先進的醫用級聚合物來生產客製化義肢。公司總部位於阿肯色州小石城,於2008年4月3日上市。該公司利用電腦輔助設計(CAD)與電腦輔助製造(CAM)技術生產客製化義肢,其工程部門採用生物電腦輔助設計(Bio-CAD)與電腦輔助製造(CAM)技術,提供可複製的顱骨植入物,以取代受損的骨結構。其產品PEEK-Optima經設計具有生物相容性。根據患者的電腦斷層掃描(CT)資料,其3D BIO-CAD/CAM軟體可將缺陷邊緣的細節直接轉移到植入物邊緣。該公司的應急計畫ke24可在約24小時內提供精準複製、針對患者個別需求的顱骨植入物。公司透過獨立經銷商和銷售代表在全美國範圍內銷售其產品。
KLYG stock price ended at $0.14 on 星期一, after rising 16.67%
On the latest trading day Feb 09, 2026, the stock price of KLYG rose by 16.67%, climbing from $0.13 to $0.14. During the session, the stock saw a volatility of 7.69%, with prices oscillating between a daily low of $0.13 and a high of $0.14. Notably, trading volume dropped by 8.9K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 10.4K shares were traded, equating to a market value of approximately $7.0M.